The transcription factor FOXM1c is activated by protein kinase CK2, protein kinase A (PKA), c-Src and Raf-1

Biochemical and Biophysical Research Communications

Volumn 413, Issue 2, 2011, Pages 230-235

  Wierstra, Inken ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

C Src; FOXM1; Protein kinase A (PKA); Protein kinase CK2; Raf 1; Transcription

Indexed keywords

CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN TYROSINE KINASE; RAF PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1C; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DELETION MUTANT; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

CASEIN KINASE II; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 80053125475     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.075     Document Type: Article

References (26)

1. Wierstra I., Alves J. FOXM1c transactivates the human c-myc promoter directly via the two TATA-boxes P1 and P2. FEBS J. 2006, 273:4645-4667.
2. Wierstra I., Alves J. Despite its strong transactivation domain transcription factor FOXM1c is kept almost inactive by two different inhibitory domains. Biol. Chem. 2006, 387:963-976.
3. Wierstra I., Alves J. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4. Biol. Chem. 2006, 387:949-962.
4. Wierstra I., Alves J. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2 and cyclin A/Cdk1, but repressed by GSK-3α. Biochem. Biophys. Res. Commun. 2006, 348:99-108.
5. Wierstra I., Alves J. Cyclin E/Cdk2, P/CAF and E1A regulate the transactivation of the c-myc promoter by FOXM1. Biochem. Biophys. Res. Commun. 2008, 368:107-115.
6. Lüscher-Firzlaff J.M., Westendorf J.M., Zwicker J., Burkhardt H., Henriksson M., Müller R., Pirollet F., Lüscher B. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation. Oncogene 1999, 18:5620-5630.
7. Lüscher-Firzlaff J.M., Lilischkis R., Lüscher B. Regulation of transcription factor FOXM1c by cyclin E/CDK2. FEBS Lett. 2006, 580:1716-1722.
8. Scott J.D., Dell'Acqua M.L., Fraser I.D., Tavalin S.J., Lester L.B. Coordination of cAMP signaling events through PKA. Adv. Pharmacol. 2000, 47:175-207.
9. Skalhegg B.S., Tasken K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. 2000, 5:D678-D693.
10. Kennelly P.J., Krebs E.G. Consesnsus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 1991, 266:15555-15558.
11. Kemp B.E., Pearson R.B. Protein kinase recognition sequence motifs. Trends Biochem. Sci. 1990, 15:342-346.
12. Pearson R.B., Kemp B.E. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulation. Methods Enzymol. 1991, 200:63-81.
13. Ubersax J.A., Ferrell J.E. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 2007, 8:530-541.
14. Laoukili J., Alvarez M., Meijer L.A.T., Stahl M., Mohammed S., Kleij L., Heck A.J.R., Medema R.H. Activation of FoxM1 during G2 requires CyclinA/Cdk-dependent relief of auto-repression by the FoxM1 N-terminal domain. Mol. Cell. Biol. 2008, 28:3076-3087.
15. Alvarez-Fernandez M., Halim V.A., Krenning L., Aprelia M., Mohammed S., Heck A.J., Medema R.H. Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep. 2010, 11:452-458.
16. Pinna L.A. Protein kinase CK2: a challenge to canons. J. Cell Sci. 2002, 115:3873-3878.
17. Litchfield D.W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 2003, 369:1-15.
18. M. Alvarez-Fernandez, V.A. Halim, M. Aprelia, S. Mohammed, R.H. Medema, Protein phosphatase 2A (B55α) prevents premature activation of transcription factor FOXM1 by antagonizing cyclin A/cyclin dependent kinase mediated phosphorylation, J. Biol. Chem. (2011) E-pub.
19. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 2004, 4:470-480.
20. Levin V.A. Basis and importance of Src as a target in cancer. Cancer Treat. Res. 2004, 119:89-119.
21. Hindley A., Kolch W. Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J. Cell Sci. 2002, 115:1575-1581.
22. Wellbrock C., Karasarides M., Marais R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 2004, 5:875-885.
23. Leicht D.T., Balan V., Kaplun A., Singh-Gupta V., Kaplun L., Dobson M., Tzivion G. Raf kinases: function, regulation and role in human cancer. Biochim. Biophys. Acta 2007, 1773:1196-1212.
24. Laoukili J., Stahl M., Medema R.H. FoxM1: at the crossroads of ageing and cancer. Biochim. Biophys. Acta 2007, 1775:92-102.
25. Wierstra I., Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol. Chem. 2007, 388:1257-1274.
26. Kalin T.V., Ustiyan V., Kalinichenko V.V. Multiple faces of FoxM1 transcription factor. Lessons from transgenic mouse models. Cell Cycle 2011, 10:396-405.